Drug Development Opportunities in China: Regulation, key players and initiatives for domestic and international markets

Drug developments in the US and EU are becoming increasingly expensive and time consuming, with new products typically requiring investment of over 4 years and $1billion from concept to commercialization.

The Gastrointestinal Market Outlook to 2012

The Gastrointestinal Market Outlook to 2012 provides a detailed epidemiological analysis of key indications within major GIT markets, and examines the factors impacting their prevalence.

Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan

Pharmaceutical Pricing and Reimbursement examines the tactical importance of price optimization throughout the product lifecycle.

Lifestyle Drugs Market Outlook: Key Indications, Epidemiology, and Emergent Drugs

The market for lifestyle drugs has become one of the most dynamic and commercially attractive sectors in the pharmaceutical industry.

The Cancer Market Outlook to 2012  

The Cancer Market Outlook to 2012 is a new report published by Business Insights that provides comprehensive coverage of the major markets in the global cancer area, incorporating a detailed epidemiological analysis of the nine major indications and key factors impacting their prevalence.

Innovations in Bioinformatics: Emerging tools for drug discovery and development

 ‘Innovations in Bioinformatics’ is a new report published by Business Insights that provides a detailed analysis of bioinformatic developments and applications. This report examines the bioinformatic tools used to manage high-throughput data from omic technologies, systems biology modelling and biomarker discovery.

Launching Combination Products: Brand extension and franchise development strategies

 Launching Combination Products is a new report published by Business Insights that provides detailed strategic guidance for the preparation and successful execution of combination product launches. This report performs a comprehensive examination of current competitive pressures, best practices and future developments in key therapeutic areas including cardiovascular, respiratory, HIV and women’s health.

The Cardiovascular Disorders Market Outlook to 2012 is a new report published by Business Insights that provides comprehensive coverage of every class of drugs across all major cardiovascular indications.